scholarly journals Omega 3 fatty acids in the elderly

2012 ◽  
Vol 107 (S2) ◽  
pp. S137-S151 ◽  
Author(s):  
Natalia Úbeda ◽  
María Achón ◽  
Gregorio Varela-Moreiras

Population ageing affects the entire world population. Also at world level one can observe a sharp increase in the proportion of older people. The challenge posed by population ageing translates into ensuring that the extra years of life will be as good as possible, free from high-cost dependency. Omega-3 fatty acids are now generally recognized as potential key nutrients to prevent the pathological conditions associated to the aging process. Ageing physiological process, its association with quality of life and the impact of omega-3 fatty acids intake and/or status is the focus of the present review. This report deals with the effects of omega-3 fatty acids on normal aging of older adults ( ≥  65 years) mainly on the effects such as nutritional status itself, cognition, bone health, muscle tonus, and general health status. The preliminary broad search of the literature on the effects of omega-3 fatty acids on normal aging yielded 685 citations. Forty two full text papers were checked for inclusion and thirty six studies were finally included in this review. It may be concluded that paradoxically even though the elderly population is the largest one, the number of studies and the methodology employed clearly lacks of sufficient evidence to establish definite conclusions on the effects of omega-3 fatty acids on aging metabolism without pathological conditions and on quality of life.

2015 ◽  
Vol 33 (17) ◽  
pp. 1910-1917 ◽  
Author(s):  
Dawn L. Hershman ◽  
Joseph M. Unger ◽  
Katherine D. Crew ◽  
Danielle Awad ◽  
Shaker R. Dakhil ◽  
...  

Purpose Musculoskeletal symptoms are the most common adverse effects of aromatase inhibitors (AIs) and can result in decreased quality of life and discontinuation of therapy. Omega-3 fatty acids (O3-FAs) can be effective in decreasing arthralgia resulting from rheumatologic conditions and reducing serum triglycerides. Patients and Methods Women with early-stage breast cancer receiving an AI who had a worst joint pain/stiffness score ≥ 5 of 10 using the Brief Pain Inventory–Short Form (BPI-SF) were randomly assigned to receive either O3-FAs 3.3 g or placebo (soybean/corn oil) daily for 24 weeks. Clinically significant change was defined as ≥ 2-point drop from baseline. Patients also completed quality-of-life (Functional Assessment of Cancer Therapy–Endocrine Symptoms) and additional pain/stiffness assessments at baseline and weeks 6, 12, and 24. Serial fasting blood was collected for lipid analysis. Results Among 262 patients registered, 249 were evaluable, with 122 women in the O3-FA arm and 127 in the placebo arm. Compared with baseline, the mean observed BPI-SF score decreased by 1.74 points at 12 weeks and 2.22 points at 24 weeks with O3-FAs and by 1.49 and 1.81 points, respectively, with placebo. In a linear regression adjusting for the baseline score, osteoarthritis, and taxane use, adjusted 12-week BPI-SF scores did not differ by arm (P = .58). Triglyceride levels decreased in patients receiving O3-FA treatment and remained the same for those receiving placebo (P = .01). No between-group differences were seen for HDL, LDL, or C-reactive protein. Conclusion We found a substantial (> 50%) and sustained improvement in AI arthralgia for both O3-FAs and placebo but found no meaningful difference between the groups.


2018 ◽  
Vol 17 (1) ◽  
pp. 1-12
Author(s):  
Pedro Javier Rodríguez-Hernández ◽  
Alejandro Canals-Baeza ◽  
Alicia Santamaria-Orleans ◽  
Ferran Cachadiña-Domenech

Author(s):  
Ondine van de Rest ◽  
M. Yulianto Kurniawan ◽  
Lisette CPGM de Groot

Pancreatology ◽  
2014 ◽  
Vol 14 (3) ◽  
pp. S109
Author(s):  
John Isherwood ◽  
Ali Arshad ◽  
Francois Runau ◽  
Jill Cooke ◽  
Cristina Pollard ◽  
...  

2014 ◽  
Vol 21 (4) ◽  
pp. 275-287 ◽  
Author(s):  
Simin Dashti-Khavidaki ◽  
Afshin Gharekhani ◽  
Mohammad-Reza Khatami ◽  
Elham-Sadat Miri ◽  
Hossein Khalili ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document